Overcoming Barriers to Biosimilar Adoption through Coordinated Efforts

ACPE UAN #:  0233-0000-20-042-H04-P

Release Date:  October 21, 2020

Expiration Date:   October 21, 2023

Activity Type:    Knowledge-based

Contact Hours:   1

Activity Fee:  Member:  $15        Non-Member:  $30

Target Audience: Pharmacists who practice in managed care settings.

Activity Description

Biosimilars are considered a fundamental pillar to containing drug spend in today’s health care systems. Unfortunately, biosimilars are having a difficult time penetrating the market and face many barriers to their acceptance among both providers and payers. These barriers often delay the acceptance of biosimilars as legitimate treatment options and impede the uptake of biosimilar utilization for years after their approval. As managed care pharmacists, it is important that we are knowledgeable and prepared to address all the common barriers to biosimilar utilization so that we can promote cost effective evidence-based medicine.

This session will provide the diverse perspectives of pharmacists throughout one IDN, their coordinated efforts to address barriers to biosimilar utilization both within the integrated delivery network (IDN) and with third-party physician offices, real-world evidence used to support biosimilar use, and the IDN’s experience as it has adopted a “biosimilar first” culture.

Learning Objectives:

At the completion of this activity, participants should be able to:

  1.  Recognize barriers to the utilization of biosimilars.
  2.  Explain current evidence supporting the use of biosimilars in different patient populations.
  3.  Describe interventions used to promote the use of biosimilars at different health care settings.
  4.  Discuss the experience and outcomes achieved of one IDN’s efforts to promote biosimilar   utilization. 

Schedule of Educational Activity:

This activity consists of an audio recording, pre-test assessment questions (not required to pass to continue), post-test questions (required to pass with a score of 70% or higher), and a specific activity evaluation.

Accreditation Statement:

The Academy of Managed Care Pharmacy (AMCP) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education

As an accredited provider, AMCP strictly adheres to the ACPE Standards for Commercial Support and other relevant guidelines and standards to ensure the independence of continuing pharmacy education (CPE) activities.  AMCP intends that all CPE activities be independent, objective, balanced, evidence-based, and free of any commercial bias.

CPE Requirements:   

Participants should claim CPE credit for this home study activity only if they have not claimed credit for the live activity presented at AMCP Nexus 2020 Virtual.


CPE credit will be processed through the AMCP Learn portal and reported directly to CPE Monitor.  Please allow 72 hours for processing and posting in your National Association of Boards of Pharmacy (NABP) e-Profile account.

To receive credit for a home study activity you must:

  •  Review the full content of the home study activity.
  •  Complete the post-test and achieve a score of 70% or higher.
  •  Complete a specific activity evaluation.

System Technical Requirements/Viewing Requirements

Courses and continuing education activities are delivered via your Web browser and Acrobat PDF.  For all activities, you should have a basic comfort level using a computer and navigating websites. View the minimum technical and system requirements for all continuing education activities. 


Credit Information

Activity Number Credit Amount Accreditation Period
ACPE UAN #0233-0000-20-042-H04-P 1 Contact Hour October 21, 2020 - October 21, 2023